Skip to content

    Recently Viewed


      It’s time to end drug-resistant tuberculosis: The case for action

      Share Article
      share to

      A new report published by The Economist Intelligence Unit (EIU), and with support from Johnson & Johnson, emphasizes the urgent need for focused global action to address the growing threat of DR-TB. Through innovative partnerships and collaborations, Johnson & Johnson is working to create world without DR-TB and end TB.

      Learn more about the report here.

      You are now leaving and going to a site with a different privacy policy. Please click below to continue to that site.